Judge orders pharmaceutical company to pay $1.5 billion in opioid case

(The Center Square) – A judge on Friday ordered a pharmaceutical company to pay $1.086 billion in criminal fines and $450 million in criminal forfeiture for misleading doctors about the safety of an opioid medication.

It was the the second-largest set of criminal financial penalties ever levied against a pharmaceutical company for violations of the Federal Food, Drug and Cosmetic Act, according to the U.S. Department of Justice.

Endo Health Solutions Inc., which previously filed for bankruptcy, was hit with penalties related to the distribution of the opioid medication Opana ER with INTAC.

When the company pleaded guilty last month, it “admitted that certain sales managers were aware that the sales representatives were making claims of purported abuse deterrence, tamper resistance and/or crush resistance when marketing Opana ER to prescribers, and that certain sales representatives were striking non-medicated sample pills with hammers and conducting other demonstrations to convey the message that
Read more…

Please follow and like us: